Supplementary Tables – Attitudes towards pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention

Supplemental Table 1: Average Participant Responses to Questions Assessing Attitudes Toward PGx Testing on a Scale of 1 (Strongly Disagree) to 5 (Strongly Agree) Supplemental Table 2: Average Participant Responses to Questions Assessing Ethics of PGx Testing on a Scale of 1 (Strongly Disagree) to 5 (Strongly Agree)